Abstract:Langerhans cells (LCs) have been the subject of much research since their discovery in 1868. LCs belong to the subset of leucocytes called dendritic cells. They are present in the epidermis and the pilosebaceous apparatus and monitor the cutaneous environment for changes in homeostasis. During embryogenesis, a wave of yolk sac macrophages seed the fetal skin. Then, fetal liver monocytes largely replace the yolk sac macrophages and comprise the majority of adult LCs. In the presence of skin irritation, LCs process antigen and travel to regional lymph nodes to present antigen to reactive T lymphocytes. Changes in LCs' surface markers during the journey occur under the influence of cytokines. The difference in expression of surface markers and the ability to resist radiation have allowed researchers to differentiate LCs from the murine Langerin-positive dermal dendritic cells. Exciting discoveries have been made recently regarding their role in inflammatory skin diseases, cancer and HIV. New research has shown that antibodies blocking CD1a appear to mitigate inflammation in contact hypersensitivity reactions and psoriasis. While it has been established that LCs have the potential to induce effector cells of the adaptive immune system to counter oncogenesis, recent studies have demonstrated that LCs coordinate with natural killer cells to impair development of squamous cell carcinoma caused by chemical carcinogens. However, LCs may also physiologically suppress T cells and permit keratinocyte transformation and tumorigenesis. Although long known to play a primary role in the progression of HIV infection, it is now understood that LCs also possess the ability to restrict the progression of the disease. There is a pressing need to discover more about how these cells affect various aspects of health and disease; new information gathered thus far seems promising and exciting.

LB1048 TGFβ/Smad2/4 Signaling Pathway is Required for Epidermal Langerhans Cell Repopulation under Inflammation Condition but Not for Their Homeostasis, Maturation and Migration in the Steady State

Smad2/4 Signaling Pathway is Critical for Epidermal Langerhans Cell Repopulation under Inflammatory Condition but Not Required for Their Homeostasis at Steady State

A Role for Tgf Beta 1 in Langerhans Cell Biology - Further Characterization of the Epidermal Langerhans Cell Defect in Tgf Beta 1 Null Mice

Langerhans cells regulate immunity in adulthood by regulating postnatal dermal lymphatic development

Distinct human Langerhans cell subsets orchestrate reciprocal functions and require different developmental regulation

E-Cadherin is Dispensable to Maintain Langerhans Cells in the Epidermis

Convergent evolution of monocyte differentiation in adult skin instructs Langerhans cell identity

Maintenance of a Normal Thymic Microenvironment and T-cell Homeostasis Require Smad4-mediated Signaling in Thymic Epithelial Cells

Skin-Homing Regulatory B Cells Required for Suppression of Cutaneous Inflammation

Role of Smad and Non-Smad Signals in the Development of Th17 and Regulatory T Cells (49.3)

The recognition of Langerhans cell-related cytokines

Targeted Disruption of SMAD3 Results in Impaired Mucosal Immunity and Diminished T Cell Responsiveness to TGF-beta.

Langerhans cells and skin immune diseases

Dynamic Regulation of the Molecular Mechanisms of Regulatory T Cell Migration in Inflamed Skin

Langerhans cell: exciting developments in health and disease

Differential Requirements Of Tcr Signaling In Homeostatic Maintenance And Function Of Dendritic Epidermal T Cells

Characterization of Smad3 knockout mouse derived skin cells

The Requirement of Membrane Lymphotoxin for the Presence of Dendritic Cells in Lymphoid Tissues

Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

Regulatory T cells promote innate inflammation after skin barrier breach via TGF-β activation